News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Jan 9, 2020 Corporate and finance Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference Download Nov 7, 2019 Corporate and finance Novavax Reports Third Quarter 2019 Financial Results Download Oct 31, 2019 Corporate and finance Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2019 Download Oct 15, 2019 Seasonal influenza Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults Download Sep 19, 2019 Corporate and finance Novavax to Present at the Ladenburg Thalmann 2019 Healthcare Conference Download Sep 6, 2019 Corporate and finance Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference Download Aug 12, 2019 RSV New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting Download Aug 8, 2019 RSV Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting Download Aug 7, 2019 Corporate and finance Novavax Reports Second Quarter 2019 Financial Results Download Aug 5, 2019 Seasonal influenza Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu Download Aug 1, 2019 Corporate and finance Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019 Download Jul 31, 2019 Partnerships Novavax and Catalent Announce Closing of Strategic Partnership Download Jun 27, 2019 Partnerships Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities Download Jun 27, 2019 Seasonal influenza Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™ Download Jun 10, 2019 RSV Novavax Provides Updates on the Global Pathways to Licensure for ResVax™ Download Jun 4, 2019 Seasonal influenza Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention Download May 10, 2019 Corporate and finance Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023 Download May 8, 2019 Corporate and finance Novavax Announces Reverse Stock Split of Common Stock Download May 2, 2019 Corporate and finance Novavax Reports First Quarter 2019 Financial Results Download May 1, 2019 RSV Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases Download Apr 25, 2019 Corporate and finance Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019 Download Apr 9, 2019 RSV Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress Download Mar 18, 2019 Corporate and finance Novavax Reports Fourth Quarter and Year-End 2018 Financial Results Download Mar 11, 2019 Corporate and finance Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019 Download Feb 28, 2019 RSV Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization Download Jan 3, 2019 Seasonal influenza Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults Download Jan 2, 2019 Corporate and finance Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference Download Dec 4, 2018 Corporate and finance Novavax Announces Leadership Promotions Download Nov 12, 2018 Corporate and finance Novavax Expands Leadership with Several Key Management Promotions Download Nov 7, 2018 Corporate and finance Novavax Reports Third Quarter 2018 Financial Results Download Nov 1, 2018 Corporate and finance Novavax Appoints Rachel King to Board of Directors Download Nov 1, 2018 Corporate and finance Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018 Download Oct 2, 2018 RSV Novavax to Highlight RSV Program Data at Two Upcoming Meetings Download Sep 26, 2018 Corporate and finance Novavax to Present at Two Upcoming Investor Conferences Download Sep 25, 2018 Seasonal influenza Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults Download Aug 28, 2018 Corporate and finance Novavax to Participate at Two Upcoming Investor Conferences Download Aug 8, 2018 Corporate and finance Novavax Reports Second Quarter 2018 Financial Results Download Aug 1, 2018 Corporate and finance Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018 Download Jun 13, 2018 Seasonal influenza New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data Download May 31, 2018 Corporate and finance Novavax CEO to Discuss Future of Global Vaccine Business as Part of Panel of Industry Leaders at 2018 BIO International Convention Download May 9, 2018 Corporate and finance Novavax Reports First Quarter 2018 Financial Results Download May 7, 2018 RSV Novavax Reaches Significant Enrollment Milestone in the Prepare(TM) Phase 3 Trial of its RSV F Vaccine Download May 2, 2018 Corporate and finance Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018 Download Apr 16, 2018 Corporate and finance Novavax Announces Closing of Public Offering Download Apr 11, 2018 Corporate and finance Novavax Announces Proposed Public Offering of Common Stock Download Apr 11, 2018 Corporate and finance Novavax Prices Public Offering of Common Stock Download Apr 2, 2018 Seasonal influenza Novavax to Present Clinical Data on RSV F and NanoFlu™ Vaccines at World Vaccine Congress Download Mar 14, 2018 Corporate and finance Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer Download Mar 14, 2018 Corporate and finance Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results Download Mar 7, 2018 Corporate and finance Novavax to Host Conference Call and Webcast to Provide Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results Download Show 5102550100 per page«123456789»